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The aim of this study was to develop chitosan-based materials
in drug delivery systems possessing covalent attachment of thiol
moieties. Thiol-containing chitosan (TCS), found to be soluble in
water, was synthesized by graft copolymerization technique. The
TCS beads were prepared by using tripolyphoshate, at pH 4.0.
The morphology of TCS beads was examined by scanning elec-
tron microscopy. The in vitro drug release behavior was studied in
phosphate buffer solution at various pH, using indomethacin as a
model drug at two different concentrations (0.3 and 0.6% w/w).
The release amounts of indomethacin from TCS beads were higher
increasing pHs in the dissolution medium. The release rate of in-
domethacin at pH 7.4 was higher than the release rate at pH 1.4 due
to ionization of thiol groups and high solubility of indomethacin in
an alkaline medium. These results indicated that the TCS beads
may become a delivery system for the controlled release of differ-
ent drugs wherever pH sensitive mechanics might be useful. This
is especially applicable in cases when it is important to minimize
drug release in acidic sites, such as in the stomach.
Keywords Beads, Indomethacin, Thiol-Containing Chitosan, TPP
Chitosan (CS) is obtained by alkaline deacetylation of chitin,
which is one of the most abundant polysaccharides in nature.
Shell wastes of shrimp, lobster, and crab are the main industrial
sources of chitin (Muzzarelli 1997; Sorlier et al. 2001). CS is a
polysaccharide consisting of copolymers of glucosamine and N-
acetylglucosamine. The primary amino group accounts for the
possibility of relatively easy chemical modification of chitosan
and salt formation with acids. At acidic pH the amino groups are
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protonated, which promotes solubility, whereas chitosan is insol-
uble at alkaline and neutral pH (Fini and Orienti 2003). Because
of its favorable properties, such as enzymatic biodegradability,
nontoxicity, and biocompatibility (Muzzarelli 1997; Sorlier et al.
2001; Fini and Orienti 2003), chitosan has received consider-
able attention as a novel carrier in drug delivery systems and has
been included in the European Pharmacopoeia since 2002. So
far, chitosan has been utilized in various fields of pharmaceuti-
cal dosage forms, such as tablets, gels, and microspheres, and as
mucoadhesive and/or permeation-enhancing excipient for oral,
nasal, ocular, and buccal drug delivery (Takeuchi, Yamamoto,
and Kawashima 2001; Felt et al. 1999; Senel et al. 2000), and
in nonviral gene delivery (Borchard 2001; Liu and Yao 2002).
Interest is a growing in the chemical modification of CS to
improve its solubility and widen its applications (Sugimoto,
Morimoto, and Sashiwa 1998; Sashiwa and Shigemasa 1999;
Heras, Rodriguez, and Ramos 2001). Among various methods,
graft copolymerization is most attractive because it is a useful
technique for modifying the chemical and physical properties of
natural polymers. CS bears two types of reactive groups that can
be grafted. First, the free amino groups on deacetylated units and
second, the hydroxyl groups on the C3 and C6 carbons deacety-
lated units. Grafting of CS allows the formation of functional
derivatives by covalent binding of a molecule, the graft, onto the
CS backbone. Recently different researchers showed that after
primary deviation followed by graft modification, CS would ob-
tain much improved water solubility and bioactivities such as
antibacterial and antioxidant properties (Xie et al. 2001, 2002;
Jayakumar et al. 2005). Grafting CS is a common way to im-
prove chitosan properties such as increasing chelating (Yang and
Yuan 2001) or complexation properties (Chen and Wang 2001),
bacteriostatic effect (Jung et al. 1999), or enhancing adsorption
properties (Kotze et al. 1997; Thanou, Verhoef, and Junginger
2001). Although the grafting of CS modifies its properties, it
is possible to maintain some interesting characteristics such as
mucoadhesivity (Hoffman et al. 1997), biocompatibility (Tasker
et al. 1998; Ono et al. 2000), and biodegradability (Singh and
Ray 1998).
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When compared with other modified-chitosan materials, thi-
olated chitosans have numerous advantageous features, such as
significantly improved mucoadhesive and permeation enhanc-
ing properties (Schnurch and Hornof 2001; Kast and Schnurch
2001; Hornof, Kast, and Schnurch 2003; Schnurch, Brandt, and
Clausen 1999, 2003; Clausen, Kast, and Schnurch 2002). More-
over, solutions of thiolated chitosans display in situ gelling prop-
erties at physiological pH values (Hornof et al. 2003). The strong
cohesive properties of thiolated chitosans make them highly suit-
able carriers for controlled drug release applications (Schnurch
et al. 1999; Kast et al. 2002).
However, to our knowledge no work has been published
on thiolated-chitosan particles or beads and its applications in
the delivery of drugs and other substances. In this work, thi-
olactic acid was grafted into chitosan by using 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide by means of coupling re-
action. The grafted chitosan was used for the preparation of
beads using tripolyphosphate to improve using this controlled
release system in contact with a gastric fluid, for instance. The
morphological features of the system, swelling properties, and
the in vitro drug release profiles of the prepared beads have been
evaluated.
MATERIALS AND METHODS
Chitosan (deacetylation degree 75–85%), tripolyphosphate
(TPP), and thiolactic acid were received from Aldrich (Milwao-
kee, WI, USA). 1-ethyl-3-(3-dimethylaminopropyl) carbodi-
imide (EDC) was received from Alfa Aesar Company (Ward
Hill, MA, USA). Indomethacin drug was purchased from Fluka
(Buchs, Switzerland). All other materials used were analytical
grade.
Synthesis of Thiol-Containing Chitosan (TCS)
CS (0.1650 g) was dissolved in 1% w/w acetic acid solu-
tion. Then thiolactic acid (0.1055 g) was dissolved in water and
then added dropwise to the CS solution. Then, EDC (0.1552 g)
was added to the above reaction mixture. The pH of the solu-
tion was maintained at 5.0. The reaction was conducted at 50◦C
for 7 hr. Then the reaction mixture was poured into acetone so-
lution (200 mL) for precipitation. The precipitate was washed
repeatedly with ethanol and acetone. The product was dried in
vacuum at room temperature. The synthesis of TCS was shown
in Diagram 1.
Preparation of TCS Beads
Thiol-containing chitosan TCS beads were prepared by using
ionotropic gelation process with counter polyanion TPP. TCS
(0.7006 g) was dissolved in 10 ml of a 2% w/w acetic acid
solution and stirred for 1 day to obtain a transparent and homo-
geneous solution. The TCS solution with or without drug was
dropped through a syringe needle (0.5 mm in diameter) into the
10% TPP aqueous phase. Solidified white beads were formed
immediately and allowed to stand for 1 hr in the solution with
DIAG. 1. Synthesis of thiol-containing chitosan.
occasional agitation at room temperature. The pH of the TPP
solution was adjusted to pH 4.0 with a 1M HCl solution. The
gel beads were filtered, washed with distilled water repeatedly,
and dried under vacuum at room temperature for 2 days. For the
preparation of drug-loaded TCS beads two different amounts
of indomethacin (IM) (0.3 and 0.6% w/w with respect to TCS
solution) were dispersed in 10 g of TCS solution for 1 day. IM
is a nonsteroid anti-inflammatory drug (NSAID) used to treat
arthrthitis (Mi et al. 2002a). The advantages of such controlled
release formulations containing NSAID over the conventional
dosage forms were reported earlier (Kulkarni et al. 1999, 2001).
Such formulations help to minimize the serious gastric irritation
side effects of the conventional-dosage NSAID formulations.
CS beads with or without IM were prepared from the same
procedure.
Swelling Tests
Dried CS and TCS beads were carefully weighed and im-
mersed in phosphate buffer media (50 mL) with pH values at
1.4 and 7.4 at 37◦C. At predetermined time intervals, swollen
beads were taken out, and the excess water was blotted with fil-
ter paper from the surface, and then weighed on a sensitive bal-
ance. The following equation was used to determine the swelling
degree.
Swelling degree [%] = {(Xw − Xd )/Xd}× 100 [1]
Here Xd and Xw represent the mass of dry and swollen beads,
respectively.
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FIG. 1. FTIR spectrum of (a) CS (b) TCS.
Determination of Drug-Loading Efficiency
During the bead preparation process, the aqueous phase was
collected, and the drug content in the aqueous phase was de-
termined by ultraviolet spectrophotometer at 320 nm. Then the
loading efficiency during bead preparation process was calcu-
lated by the following formula:
Loading efficiency [%] = {(m − c × v)/m}× 100 [2]
Where m, c, and v represent the initial drug (IM) mass in beads
(TCS) droplet, the IM concentrations in TPP solution, and the
volume of TPP solution, respectively.
In Vitro Drug Release Studies
The in vitro release tests were carried out on all formulations
of drug-loaded CS beads, and TCS beads were suspended in
100 mL of phosphate buffer at various pH at 37◦C and placed
in an incubated shaker at 120 rpm. At predetermined time inter-
vals, 1 mL aliquot of sample was withdrawn and after suitable
dilution, the concentration of drug released was monitored by ul-
traviolet spectrophotometer at 320 nm. The dissolution medium
was replaced with fresh buffer to maintain the total volume.
The drug release percent can be determined by the following
equation:
Drug release [%] = Rt/L × 100 [3]
Where L and Rt represent the initial amount of drug loaded and
the cumulative amount of drug released at time t , respectively.
Instruments
The surface morphology of samples was analyzed by scan-
ning electron microscopy (Leica Cambridge S360 microscope,
UK). The drug release was monitored by ultraviolet spectropho-
tometer (Shimadzu UV-1601, Japan). The infrared spectrum
was recorded with a double-beam Perkin-Elmer 1600 FTIR
spectrophotometer.
RESULTS AND DISCUSSION
Synthesis of TCS
Thiolactic acid was attached covalently to the primary amino
group of chitosan under the formation of amide bonds as shown
in Diagram 1. The carboxylic acid moieties of thiolactic acid
were activated by EDC forming as O-acylurea derivative as in-
termediate product that reacts with the primary amino groups of
chitosan. The TCS was found to be soluble in both water and
acetic acid. The yield of the TCS was 86%. The FTIR spectrum
of TCS and CS is shown in Figure 1. The FTIR spectrum of
CS (Figure 1a) showed a broad –OH stretching absorption band
between 3450 and 3100 cm−1 and the aliphatic C-H stretch-
ing between 2990 and 2850 cm−1. As the –OH stretching band
and the aliphatic C-H stretching band were appeared between
3450 and 2850 cm−1 in the spectrum, Another major absorption
band between 1220 and 1020 cm−1 represented the free primary
amino group (–NH2) at C2 position. The peak at 1647 cm−1 rep-
resented acetylated amino group of chitin, which indicated that
the sample is not fully deacetylated. The peak at 1384 cm−1
represents the –C–O stretching of primary alcoholic group
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FIG. 2. SEM pictures of (a) and (b) CS beads without drug and (c) and (d) TCS beads without drug in different magnifications.
(–CH2–OH). The adsorption peaks at 3434 cm−1 is due to
–NH stretching. The peaks at 1646 and 1578 cm−1 are due to
the formation of amide linkage (–NHCO linkage). The peaks at
1254, 1154, and 896 cm−1 are due to thiol groups. The above
peaks confirmed the structure of TCS.
SEM of Prepared TCS Beads
Figure 2 shows SEM images of drug-free CS and TCS beads.
The liquid-gel transition of TCS in TPP aqueous solution can
be explained by the electrostatic interaction between positively
charged free amino groups with negatively charged counteranion
TPP (Mi et al. 1999). The CS beads have a regular spherical
shape, smooth surface, and homogeneous polymer matrix. This
may be because cross-linking is more efficient in the CS beads.
The TCS beads have some cracks on the surface that may be due
to the grafting of thiol-containing monomer. The insufficient
cross-linking of TCS beads as the amino groups of CS were
substituted by thiol compound has lead to the formation of rough
and nonuniform surface structure. The size of the CS and TCS
beads was found to vary in between 1.5–1.75 mm.
Swelling Behaviors of Beads
The swelling behavior of the CS and TCS beads in solu-
tions of pH 1.4 and 7.4 at 37◦C are shown in Figures 3 and
4. The TCS beads at pH 1.4 were found to disintegrate within
3 days and then dissolve. The CS beads slowly swell and were
found to be dissolved after 4 days. The results could be associ-
ated with differences in cross-linking density (Lee et al. 2001).
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FIG. 3. Swelling behavior of CS and TCS beads at pH 1.4.
The lower cross-linked TCS beads swelled quickly and grad-
ually dissolved within 3 days, whereas the higher cross-linked
beads did not dissolve within the same time. This is expected
behavior, attributed to the high amount of interchain linkages in
the well cross-linked chitosan-TPP network. The swelling per-
FIG. 4. Swelling behavior of CS and TCS beads at pH 7.4.
centage was much higher at pH 1.4 than pH 7.4. Moreover, the
swelling reached a stable equilibrium much more rapidly in pH
7.4 than in pH 1.4. This is due to the lack of protonation of amino
groups at pH 7.4, which prevents swelling in alkaline medium
(Gupta and Ravi Kumar 2000).
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TABLE 1
Loading efficiencies for IM-loaded CS and TCS Beads
Initial drug Loading Loading
content level efficiency
Formulation (mg/g-beads) (mg/g-beads) (%)
0.3% IM-CS 28.9 27.1 93.81
0.6% IM-CS 58.2 53.2 91.43
0.3% IM-TCS 29.7 26.2 88.28
0.6% IM-TCS 59.4 50.7 85.47
Im= indomethacin, CS= chitosan, TCS= thiol-containia/chitosau.
Entrapment of Drug in TCS Beads
IM drug was efficiently entrapped into TCS beads during
ionotropic process (see Table 1). The relatively high efficiency
of loading could be explained by the low water solubility of
IM as well as the ionic binding between the carboxyl group
of IM and the thiol group in TCS beads. The carboxyl groups
in IM and the thiol group in TCS are ionized at pH 4. In this
work, the drug was not chemically attached to the polymer. Thus,
there will be only both electrostatic and hydrophobic interactions
as well as the effect within the polymer matrix. Therefore, the
drug is expected in a biologically active form and can exert its
therapeutically effect upon the body as soon as it is released
from the polymeric matrix.
FIG. 5. Release profiles of IM from 0.3% loaded TCS beads in various pH media.
Im In Vitro Release Profiles
Figure 5 shows the release profiles of 0.3% of IM-TCS beads
at various pH, at 37◦C. Within 3 hr, 27% of IM was released from
TCS beads at pH 1.4 and 44% at pH 7.4. These results showed
that the drug release profiles of TCS are in fact pH sensitive.
Moreover, the more noticeable changes occur within a narrow
pH range between 5.8 and 7.4. The following factors are to be
considered in the noticeably higher release rate of IM at pH 7.4
than that at pH 1.4. The first factor is the higher solubility of
IM in alkaline medium. The second factor is an electrostatic and
hydrophobic repulsion between the carboxyl group of IM and
the methyl group of modified TCS in pH 7.4 media (Hadgraft
and Valenta 2000; Mi et al. 2002). This study shows that the
percentages of drug release increase with an increasing pH in
dissolution medium. The similar drug release profile also was
observed for the CS beads. However, the release percentage of
IM at pH 1.4 was found to be less than that of TCS beads. The rea-
son may be the formation of complexes between carboxyl group
of IM and amino group of CS and poor solubility of drug at pH
1.4 (Mi et al. 2002). The velocity of diffusion of drug molecules
is higher in the alkaline medium, effectively contributing to the
controlled drug release. The polymer matrix probably combines
two types of mechanisms for drug release: controlled diffusion
and swelling.
Thiolated chitosans also display, besides their strong
mucoadhesive and permeation-enhancing properties, excellent
cohesive properties. The reducing thiol functions on the chitosan
backbone enable the glycol proteins to also form inter- as well
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FIG. 6. Drug release from 0.3 and 0.6% of IM-loaded TCS beads in simulated gastric fluid, pH 1.4, and simulated intestinal fluid, pH 7.4.
as intramolecular disulfide bonds. Such a cross-linking of the
polymeric chains results in a high stability of drug carrier sys-
tems based on thiolated chitosans (Schnurch, Hornof, and Guggi
2004). Figure 6 shows the influence of the initial drug loading
FIG. 7. Release profiles for initially 0.6% IM-loaded CS and TCS beads in simulated gastric fluid, pH 1.4, and simulated intestinal fluid, pH 7.4.
on the release percent of IM drug from TCS beads at pH 1.4 and
7.4. There is no significant change between the release trends
of 0.3 and 0.6% IM-loaded TCS beads. The amount of drug re-
leased from high drug-loaded beads is higher than that from low
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drug-loaded beads. Increasing the initial drug content provides
the larger equilibrium amount of drug released in each pH.
Figure 7 shows the in vitro release profiles of 0.6% IM-
loaded CS and TCS beads investigated at pH 1.4 and 7.4. At
pH 1.4, 25% of IM was released from CS beads within 3 hr
while for TCS beads the amount of IM released was higher
(27%). Fully 38% of IM was released from CS beads at pH 7.4
within 3 hr while this value is increased to 44% of IM for TCS
beads. In the case of CS beads, the complex is formed between
the amino group of CS and carboxyl group of IM. In the TCS
beads there is a hydrophobic interaction between the carboxyl
group of IM and the methyl group of thiol-containing chitosan
(Mi et al. 2002). TCS beads released the IM drug much faster
than that of CS beads. When thinking of drug delivery appli-
cations, these improved mucoadhesive properties along with a
controlled release out of the polymer matrix should render TCS
beads very promising tools. Their positive result is due to the
expected increase of drug bioavailability by adhering to mucosal
tissues. Because of these properties, TCS beads should be further
investigated.
CONCLUSION
Novel TCS beads have been synthesized for use as a con-
trolled drug delivery system. The beads were prepared under
mild conditions at room temperature at pH 4.0, and the loading
efficiency of a model drug, indomethacin, was over 85%. The
TCS beads were found to be pH sensitive. The water solubility
of the drug, the swelling degree of beads, and the ionization of
thiol groups influenced the release profiles of the drug at vari-
ous pHs. The release rate in simulated intestinal fluid (pH 7.4)
is higher than that in simulated gastric fluid (pH 1.4), enabling
the drug delivery or release to take place preferentially in the
intestine, avoiding drug leakage in the stomach. According to
our results, TCS beads represent a promising tool as successful
drug carriers for controlled drug delivery systems.
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